Plandai Biotechnology Inc (PLPL)

[Aston Martin]

I worry those members of the stockmarket, who currently take care for stocks like PLPL , are too stupid to get your reasonable arguments. On the other hand, PLPL did not deliver anything yet which makes a company run financially. I know many biotech stocks, which promise wonderful products and receive millions to develop those products - and did not deliver anything within a decade. Plandai is not much different in this case as Pythofare is an 10-years-old priduct of Plandai and Plandai has not been able to go public with this product ready for making revenues. This is typical and not too trustworthy.
So I am cutted into two parts:
The one half says, Plandai has some opportunities, included Shively and pot., the other half says, Plandai promises again and again since 2012 to sell Phytofare, but started - after Pythofare is 10 years old, with biotechnical and medical trials only within last 6 months.
So, some seriousity is missing for me, but, still seen as a well-traded pennystock. PLPL is an opportunity. But I still do not believe everything as making debt and generating revenues is still a big discrepany here.
Maybe my fault: I should not see PLPL as an investment but only as a pennytsock speculation without any longterm hopes. Still too early I assume.